News

Explore This Section

Experienced Thought Leaders Join UCLA TDG Board of Directors

image of 3 new board members

Experienced Thought Leaders Join UCLA Technology Development Group Board of Directors

Los Angeles, CA – [Monday, October 6, 2025] – UCLA Technology Development Corp (UCLA TDC) is excited to announce the addition of three highly accomplished leaders to its Board of Directors: Michael Edelstein, Flavius Martin, and Ah-Hyung “Alissa” Park.

UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration

Photo L to R: Amir Naiberg, AVC, CEO and President, UCLA Technology Development Group, Dr. Wong, Professor, UCLA School of Dentistry and Dong-Cheol Kim, CEO, Dongwoon Anatech 

 

UCLA School of Dentistry and Dongwoon Anatech Launch Collaboration to Advance Saliva-Based Cancer Detection Technology

Sponsored Research Agreement will provide up to $787,500 annually to support Dr. David T.W. Wong's Electric Field-Induced Release and Measurement (EFIRM) platform.

UCLA TDG Innovation Magazine July 2025

UCLA TDG Innovation Magazine July 2025

It's our success story edition. Delve into >

*Bahram Jalali's Journey from Research to Commercialization

*UCLA startups that have reached media and funding milestones

*UCLA TDG updates including a new department name, Innovation Fund recipients and Ready-to-Sign Agreements

*Event wrap ups on the first LABEST Week 2025, UCLA Ventures Annual Dinner, Bruin Founders Cohorts and the quarterly Founders Mixers

and more...

Nervonik Raises $13 Million in Series A Financing

Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Relief

LOS ANGELES, March 4, 2025 /PRNewswire/ -- Nervonik, Inc. (Nervonik), a medical device company developing an opioid-free peripheral nerve stimulation (PNS) system, has successfully closed a $13 million Series A funding round. The round was led by U.S. Venture Partners (USVP), with participation from Foothill Ventures, Correlation Ventures, and other investors.